Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px
Document › Details

Charles River Laboratories International, Inc.. (3/5/18). "Press Release: Charles River Laboratories to Present at Raymond James and Barclays Conferences". Wilmington, MA.

Region Region Orlando, FL
  Country United States (USA)
Organisations Organisation Charles River Laboratories International Inc. (NYSE: CRL)
  Group Charles River (Group)
  Organisation 2 Raymond James & Associates Inc.
  Group Raymond James (Group)
Products Product Barclays Global Healthcare Conference 2018 Miami
  Product 2 drug development services
Index terms Index term Charles River–Raymond James: investor conference, 201803 supply service Charles River presents at Raymond James Institutional Investors Conference
  Index term 2 Charles River–Barclays: investor conference, 201803 supply service Charles River presents at Barclays Global Healthcare Conference
Person Person Hardy, Susan E. (Charles River 201701 VP Investor Relations)
     


Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Raymond James 39th Annual Institutional Investors Conference in Orlando, Florida, on Tuesday, March 6th, at 3:25 p.m. ET, and at the Barclays Global Healthcare Conference in Miami, Florida, on Wednesday, March 14th, at 10:15 a.m. ET. Management will present an overview of Charles River’s strategic focus and business developments.

A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after each presentation and will remain available for approximately two weeks.


About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.


Charles River Laboratories International, Inc.

Investor Relations Contact:

Susan E. Hardy, 781-222-6190
Corporate Vice President, Investor Relations
susan.hardy@crl.com

   
Record changed: 2023-06-05

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Charles River (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x300px




» top